1. Keeling DH. Adverse reactions and untoward events associated with the use of radiopharmaceuticals. In: Sampson CB, ed.Textbook of radiopharmacy theory and practice. Yverdon: Gordon and Breach Science Publishers; 1994: 285?298.
2. European Association of Nuclear Medicine Committee on Radiopharmaceuticals. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1995:Eur J Nucl Med 1996; 23: BP 27?31.
3. Silberstein EB, Ryan J and the Pharmacopoeia Committee of the Society of Nuclear Medicine. Prevalence of adverse reactions in nuclear medicine.J Nucl Med 1986; 37: 185?192.
4. Silberstein EB. Adverse reactions to radiopharmaceuticals. In: Henkin RE et al., eds.Nuclear Medicine. St. Louis: Mosby Year Book; 1996: 485?492.
5. Sub-committee of Safety Issue for Radiopharmaceuticals, Japan Radioisotope Association. The sixteenth report on survey of the adverse reaction to radiopharmaceuticals (the 19th Survey in 1993) (in Japanese).Kaku Igacu 1995; 32: 605?614.